Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL30049697

CCCC[N+](CCCC)(CCCC)CCCC.O=P([O-])(O)OP(=O)(O)O.[P+5]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.44
LPAR3 Q9UBY5 3/20 0.41
LPAR1 Q92633 2/20 0.41
LPAR2 Q9HBW0 2/20 0.41
SLC22A2 O15244 1/20 0.39
SMPD1 P17405 4/20 0.38
LMNA P02545 1/20 0.38
ESR1 P03372 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CDC25A P30304 1/20 0.38
AGTR1 P30556 1/20 0.38
AKT1 P31749 1/20 0.38
ADRA1A P35348 1/20 0.38
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
ALOX12 P18054 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL21855088 0.90 SLC22A1 (0.50) SLC22A1LPAR3LPAR1LPAR2SLC22A2
Tetrabuthylammonium SCHEMBL28421585 0.89 SLC22A1 (0.48) SLC22A1LPAR3LPAR1LPAR2SLC22A2
Tetrabuthylammonium SCHEMBL1332663 0.89 SLC22A1 (0.38) SLC22A1LPAR3LPAR1LPAR2SLC22A2
Tetrabuthylammonium SCHEMBL21496366 0.87 SLC22A1 (0.46) SLC22A1LPAR3LPAR1LPAR2SLC22A2
Tetrabuthylammonium SCHEMBL288042 0.87 SLC22A1 (0.46) SLC22A1LPAR3LPAR1LPAR2SLC22A2
Tetrabuthylammonium SCHEMBL21855087 0.86 SLC22A1 (0.55) SLC22A1LPAR3LPAR1LPAR2SLC22A2
Tetrabuthylammonium SCHEMBL1577204 0.86 SLC22A1 (0.55) SLC22A1LPAR3LPAR1LPAR2SLC22A2
Tetrabuthylammonium SCHEMBL769197 0.86 SLC22A1 (0.55) SLC22A1LPAR3LPAR1LPAR2SLC22A2
Tetrabuthylammonium SCHEMBL22034330 0.85 SLC22A1 (0.44) SLC22A1LPAR3LPAR1LPAR2SLC22A2
Tetrabuthylammonium SCHEMBL21855085 0.84 SLC22A1 (0.52) SLC22A1LPAR3LPAR1LPAR2SLC22A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4172170-B1 FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION STEALTH LABELS BIOTECH AB (SE) 2024-09-25 EP disclosed
US-20240209016-A1 FLUORESCENT NUCLEOSIDE PHOSPHATES STEALTH LABELS BIOTECH AB (SE) 2024-06-27 US disclosed
EP-4323373-A1 FLUORESCENT NUCLEOSIDE PHOSPHATES STEALTH LABELS BIOTECH AB (SE) 2024-02-21 EP disclosed
US-20230219995-A1 FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION STEALTH LABELS BIOTECH AB (SE) 2023-07-13 US disclosed
EP-4172170-A1 FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION STEALTH LABELS BIOTECH AB (SE) 2023-05-03 EP disclosed
WO-2022218943-A1 FLUORESCENT NUCLEOSIDE PHOSPHATES STEALTH LABELS BIOTECH AB (SE) 2022-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219995-A1 FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION RNGTT, CPSF1, NSUN2 SLC22A1 1917/4885LPAR3 4328/4885LPAR1 4413/4885
US-20240209016-A1 FLUORESCENT NUCLEOSIDE PHOSPHATES RNGTT, PNP, RNMT SLC22A1 1182/4885LPAR3 2568/4885LPAR1 2318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.